118 related articles for article (PubMed ID: 1654589)
1. Fine structure of Leishmania donovani in bone marrow aspirates from a patient with visceral leishmaniasis before and during treatment with sodium stibogluconate.
el-Shoura SM; Sheikha AK
Trop Med Parasitol; 1991 Jun; 42(2):119-26. PubMed ID: 1654589
[TBL] [Abstract][Full Text] [Related]
2. Electron microscopy of Leishmania donovani in splenic aspirates from patients with visceral leishmaniasis during treatment with sodium stibogluconate.
Chulay JD; Fawcett DW; Chunge CN
Ann Trop Med Parasitol; 1985 Aug; 79(4):417-29. PubMed ID: 3000304
[TBL] [Abstract][Full Text] [Related]
3. Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.
Sharief AH; Gasim Khalil EA; Theander TG; Kharazmi A; Omer SA; Ibrahim ME
Exp Parasitol; 2006 Dec; 114(4):247-52. PubMed ID: 16716301
[TBL] [Abstract][Full Text] [Related]
4. Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani.
Carter KC; Mullen AB; Sundar S; Kenney RT
Antimicrob Agents Chemother; 2001 Dec; 45(12):3555-9. PubMed ID: 11709339
[TBL] [Abstract][Full Text] [Related]
5. Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.
Sinha R; Roychoudhury J; Palit P; Ali N
Antimicrob Agents Chemother; 2015 Jan; 59(1):344-55. PubMed ID: 25367907
[TBL] [Abstract][Full Text] [Related]
6. Leishmania resistant to sodium stibogluconate: drug-associated macrophage-dependent killing.
Ibrahim ME; Hag-Ali M; el-Hassan AM; Theander TG; Kharazmi A
Parasitol Res; 1994; 80(7):569-74. PubMed ID: 7855121
[TBL] [Abstract][Full Text] [Related]
7. An experimental model system for leishmaniasis. An ultrastructural study on cultured macrophages exposed to Leishmania parasites and sodium stibogluconate.
Abok K; Fredriksson BA; Brunk U
APMIS; 1988 Jul; 96(7):589-95. PubMed ID: 2841954
[TBL] [Abstract][Full Text] [Related]
8. Effect of sodium stibogluconate and pentamidine on in vitro multiplication of Leishmania donovani in peritoneal macrophages from infected and drug-treated BALB/c mice.
Sodhi S; Kaur S; Mahajan RC; Ganguly NK; Malla N
Immunol Cell Biol; 1992 Feb; 70 ( Pt 1)():25-31. PubMed ID: 1322361
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural study on the antileishmanial effect of 1,2-dimethyl-3-methoxy carbonyl-4-(2-nitro-4,5-dimethoxyphenyl) pyrrole in hamsters.
Bhatnagar S; Maitra SC; Guru PY; Katiyar JC
Indian J Med Res; 1991 May; 93():147-51. PubMed ID: 1657768
[TBL] [Abstract][Full Text] [Related]
10. Genetic control of drug-induced recovery from murine visceral leishmaniasis.
Carter KC; Baillie AJ; Alexander J
J Pharm Pharmacol; 1993 Sep; 45(9):795-8. PubMed ID: 7903366
[TBL] [Abstract][Full Text] [Related]
11. Comparison of treatment regimens of kala-azar based on culture & sensitivity of amastigotes to sodium antimony gluconate.
Thakur CP; Thakur S; Narayan S; Sinha A
Indian J Med Res; 2008 Jun; 127(6):582-8. PubMed ID: 18765878
[TBL] [Abstract][Full Text] [Related]
12. [Visceral leishmaniasis. Personal observation and review of epidemiology, clinical aspects and therapy].
Dickerhoff R; Müller A; Bode U
Klin Padiatr; 1990; 202(5):347-51. PubMed ID: 2170739
[TBL] [Abstract][Full Text] [Related]
13. Visceral and cutaneous leishmaniasis comparative ultrastructure of host-parasite interactions.
el-Shoura SM; Sheikha AK; Bahamdan KA; Tallab TM; Hassounah OA
J Egypt Soc Parasitol; 1995 Dec; 25(3):861-76. PubMed ID: 8586879
[TBL] [Abstract][Full Text] [Related]
14. Resistance of Leishmania donovani to sodium stibogluconate is related to the expression of host and parasite gamma-glutamylcysteine synthetase.
Carter KC; Hutchison S; Henriquez FL; Légaré D; Ouellette M; Roberts CW; Mullen AB
Antimicrob Agents Chemother; 2006 Jan; 50(1):88-95. PubMed ID: 16377672
[TBL] [Abstract][Full Text] [Related]
15. Visceral leishmaniasis: drug carrier system characteristics and the ability to clear parasites from the liver, spleen and bone marrow in Leishmania donovani infected BALB/c mice.
Carter KC; Dolan TF; Alexander J; Baillie AJ; McColgan C
J Pharm Pharmacol; 1989 Feb; 41(2):87-91. PubMed ID: 2568434
[TBL] [Abstract][Full Text] [Related]
16. Leishmania donovani: effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Indian clinical isolates to sodium stibogluconate.
Valiathan R; Dubey ML; Mahajan RC; Malla N
Exp Parasitol; 2006 Oct; 114(2):103-8. PubMed ID: 16616137
[TBL] [Abstract][Full Text] [Related]
17. [Big spleen, big problems].
Boon DA; De Nef JJ; Kager PA
Tijdschr Kindergeneeskd; 1985 Dec; 53(6):224-7. PubMed ID: 3006280
[TBL] [Abstract][Full Text] [Related]
18. Experimental visceral leishmaniasis: role of trans-aconitic acid in combined chemotherapy.
Kar S; Kar K; Bhattacharya PK; Ghosh DK
Antimicrob Agents Chemother; 1993 Nov; 37(11):2459-65. PubMed ID: 8285634
[TBL] [Abstract][Full Text] [Related]
19. Visceral leishmaniasis in the BALB/c mouse: antimony tissue disposition and parasite suppression after the administration of free stibogluconate.
Collins M; Carter KC; Baillie AJ
Ann Trop Med Parasitol; 1992 Feb; 86(1):35-40. PubMed ID: 1319700
[TBL] [Abstract][Full Text] [Related]
20. Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani.
Samant M; Sahasrabuddhe AA; Singh N; Gupta SK; Sundar S; Dube A
Parasitology; 2007 Aug; 134(Pt 9):1175-84. PubMed ID: 17362540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
